Skip to content

EFFECT OF BASTI & MARMA CHIKITSA IN THE TREATMENT OF BPH & UTI

A COMPARATIVE CLINICAL STUDY OF BASTI CHIKITSA & MARMA CHIKITSA IN THE MANAGEMENT OF VATASHTHEELA(BPH) & MUTRAKRICHCHHRA (UTI)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019133
Enrollment
30
Registered
2019-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: group A: Patients under this group will be administrated per rectum basti of Narayana Taila mixed with Dashmula kwath (Alternate dose of 200 ml kwath mixed with 20 ml Taila & 60 ml kwat

Sponsors

Uttrakhand Ayurved Universty
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age â?? Above 20 years . Sex - Either sex ,males for Vatastheela Patients with clinical signs & symptoms of Vatastheela & Mutrakrichchhra

Exclusion criteria

Exclusion criteria: Uncontrolled Diabetis mellitus and hypertension Malignancy Age below 20 yrs Patient Ayogya for Basti in Classics.

Design outcomes

Primary

MeasureTime frame
ABSENT PRESENT 1.Hesitancy 0 1 2.Nocturia 0 1 3.Blood mixed Urine (Haematuria)) 0 1 4.Pressure just above Pubic 0 1 5.Fatigue 0 1 6.Fever 0 1 7.Bladder/ Pelvic/ Supra pubic Pain 0 1 Timepoint: Assessed outcome in every weak in the study of 21 days

Secondary

MeasureTime frame
â?¢ Response of Basti Chikitsa and Marma Chikitsa will be assessed at every 7th,14th& 21 day of interval on the basis of given criteriaTimepoint: at interval of 15 days, for 2 months

Countries

India

Contacts

Public ContactDr Sunil kumar joshi

Rishikul campus ,UAU,hardwar

mrityunjaymission@gmail.com9897523499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026